News
OVERLAND PARK, Kan. - Compass Minerals (NYSE: CMP) reported better-than-expected revenue for its fiscal 2025 third quarter, though earnings fell short of analyst expectations. The essential minerals ...
Investing.com -- Gevo , Inc. (NASDAQ: GEVO) shares surged 47.2% after the renewable fuels company reported its first-ever quarterly profit, beating analyst expectations with strong revenue growth ...
While revenue declined, GoPro’s gross margin improved substantially to 36.0% from 30.7% in the same quarter last year, a 530 ...
IRVING, Texas - RumbleOn Inc. (NASDAQ: RMBL) shares surged 13.5% despite reporting second-quarter results that missed analyst expectations, as investors focused on the company’s rebranding initiative ...
For fiscal year 2025, Hillenbrand updated its revenue guidance to $2.595-$2.630 billion, above the consensus estimate of $2.58 billion. The company maintained its adjusted EPS outlook at $2.20-$2.35, ...
The company reported a net loss of $34.4 million for the quarter, compared to net income of $3.7 million in Q2 2024. This decline was primarily attributed to a $57.2 million increase in foreign ...
Investing.com -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares surged 6.4% after the neuroscience-focused biopharmaceutical company reported second-quarter earnings that dramatically exceeded ...
Investing.com -- AST SpaceMobile Inc on Tuesday reported a wider second-quarter loss and revenue well below Wall Street estimates, as the satellite communications company ramped up spending to build ...
Investor sentiment turned positive following the results, with shares moving higher in after-hours trading. With a $15.7 ...
The media company posted revenue of $933.7 million for the quarter ended June 30, 2025, surpassing the consensus estimate of $912.4 million and representing a 0.5% increase YoY. Adjusted EBITDA rose 3 ...
SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported a significant revenue shortfall in the second quarter as the company continues to advance its pipeline of mRNA therapeutics and ...
Fourth-quarter adjusted EBITDA reached $51.3 million with an 18.8% margin, while free cash flow was $34.0 million. For the full fiscal year 2025, Mercury reported revenue of $912.0 million, up 9.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results